Sparrow Pharmaceuticals

0 followers


Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical developme... Read more

Industries

Headquarters

Stage

Employees

Links

Org chart

Robert Jacks
President & CEO

Robert Jacks

Collapse
David Katz
Chief Scientific Officer
Frank Czerwiec
Chief Medical Officer
Jamie MacPherson
SVP of Regulatory Affairs & Quality Assurance
Jeff Drajesk
VP of Program Management
Sarah H.
Associate Director of Clinical Operation